Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B
Science Advances · 15.12.2023 · 9 (50)
DOI: 10.1126/sciadv.adj1205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 15.12.2023. Verfasst von Prosenjit Pal und 15 weiteren Autor:innen. Beteiligte Einrichtung: MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council.
Abstract (Originalsprache)
We demonstrate that the Parkinson’s VPS35[D620N] mutation alters the expression of ~220 lysosomal proteins and stimulates recruitment and phosphorylation of Rab proteins at the lysosome. This recruits the phospho-Rab effector protein RILPL1 to the lysosome where it binds to the lysosomal integral membrane protein TMEM55B. We identify highly conserved regions of RILPL1 and TMEM55B that interact and design mutations that block binding. In mouse fibroblasts, brain, and lung, we demonstrate that the VPS35[D620N] mutation reduces RILPL1 levels, in a manner reversed by LRRK2 inhibition and proteasome inhibitors. Knockout of RILPL1 enhances phosphorylation of Rab substrates, and knockout of TMEM55B increases RILPL1 levels. The lysosomotropic agent LLOMe also induced LRRK2 kinase–mediated association of RILPL1 to the lysosome, but to a lower extent than the D620N mutation. Our study uncovers a pathway through which dysfunctional lysosomes resulting from the VPS35[D620N] mutation recruit and activate LRRK2 on the lysosomal surface, driving assembly of the RILPL1-TMEM55B complex.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.
- Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA.
- Department of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305-5307, USA.
ORCID-Profile: Prosenjit Pal, Matthew Taylor, Pui Yiu Lam, Francesca Tonelli, Chloe A Hecht, Pawel Lis, Raja S Nirujogi, Toan K Phung, Wondwossen M Yeshaw, Ebsy Jaimon, Rotimi Fasimoye, Emily A Dickie, Thomas Macartney, Suzanne R Pfeffer, Dario R Alessi
Förderung
- Medical Research Council
Zitieren
APA
Pal, P., Taylor, M., Lam, P. Y., Tonelli, F., Hecht, C. A., Lis, P., Nirujogi, R. S., Phung, T. K., Yeshaw, W. M., Jaimon, E., Fasimoye, R., Dickie, E. A., Wightman, M., Macartney, T., Pfeffer, S. R., & Alessi, D. R. (2023). Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B. Science Advances, 9(50). https://doi.org/10.1126/sciadv.adj1205
Vancouver
Pal P, Taylor M, Lam PY, Tonelli F, Hecht CA, Lis P, et al. Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B. Science Advances. 2023;9(50). doi:10.1126/sciadv.adj1205
BibTeX
@article{Pal2023,
author = {Pal, Prosenjit and Taylor, Matthew and Lam, Pui Yiu and Tonelli, Francesca and Hecht, Chloe A and Lis, Pawel and Nirujogi, Raja S and Phung, Toan K and Yeshaw, Wondwossen M and Jaimon, Ebsy and Fasimoye, Rotimi and Dickie, Emily A and Wightman, Melanie and Macartney, Thomas and Pfeffer, Suzanne R and Alessi, Dario R},
title = {Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {50},
doi = {10.1126/sciadv.adj1205}
}
EUVIMED